Beyond the Hype: Evidence-Based Insights into PRP for Joint Pain

Medically Reviewed Reviewed by DR JOHN PRP
This article has been reviewed for medical accuracy by a licensed physician with experience in integrative health.

Share:

Table of Contents

How strong is the case for PRP for joint pain? The evidence for PRP therapy in orthopaedics is growing. Multiple randomised controlled trials support its use for knee osteoarthritis, tendinopathy, and soft tissue injuries. It is not simply hype. Learn about the PRP procedure and see the published clinical evidence.

Understanding the mechanism of action

To appreciate the evidence, it’s important to grasp how PRP is theorised to work. PRP contains concentrated platelets, which are rich in various growth factors. When injected into an injured joint or tissue, these growth factors are released, initiating and accelerating the natural healing process. They are believed to:

  • Stimulate cell proliferation and differentiation, aiding in tissue repair.
  • Promote angiogenesis (formation of new blood vessels), improving blood supply to injured areas.
  • Reduce inflammation, which can contribute to pain and tissue degradation in joints.
  • Influence the extracellular matrix, providing a scaffold for new tissue growth.

This biological cascade is the foundation upon which the potential benefits of PRP are built.

Evidence for osteoarthritis

Osteoarthritis (OA) is perhaps the most widely studied application of PRP in joint pain. Research, particularly for knee osteoarthritis, has shown promising results. Numerous clinical studies and systematic reviews point to clear benefits. PRP injections can significantly reduce pain and improve function in patients with mild to moderate knee OA. Some studies suggest PRP may outperform hyaluronic acid injections and placebo. This advantage covers pain relief and functional improvement over the short to medium term, up to 12 months. PRP does not typically regenerate lost cartilage. Instead, it appears to modify the joint environment, reducing inflammation and potentially slowing cartilage degeneration in some cases. Evidence for other joints, such as the hip and shoulder, is also emerging. It is perhaps not yet as robust as the evidence for the knee.

Evidence for chronic tendon injuries

PRP has also shown promise for chronic tendinopathies. These include tennis elbow (lateral epicondylitis), Achilles tendinopathy, and patellar tendinopathy. These conditions often involve degenerative changes in tendons with poor healing. Studies indicate that PRP injections can reduce pain and improve function in chronic tendon issues. This is especially true for patients who have not responded to conservative treatments. The rationale is straightforward. PRP delivers concentrated growth factors directly to the degenerated tendon, stimulating a healing response and promoting tissue remodelling. While results can vary, many patients report significant improvements.

Evidence for ligament injuries

For acute and chronic ligament injuries, particularly partial tears, the evidence for PRP is growing. Ligaments have a limited blood supply, making healing challenging. PRP delivers growth factors directly to the injured ligament. This is thought to enhance the natural repair process and potentially improve strength and stability. More large-scale studies are still needed. Even so, preliminary research suggests PRP may accelerate recovery in conditions like medial collateral ligament (MCL) sprains of the knee and ankle sprains.

What the evidence doesn’t say (and why)

It’s important to temper enthusiasm with realistic expectations based on the current evidence.

  • Not a miracle cure: PRP is not a cure-all for all joint pain or orthopaedic injuries. Its effectiveness varies depending on the specific condition, severity, and individual patient factors.
  • Limited evidence for severe degeneration: For severe osteoarthritis with significant cartilage loss, PRP may offer symptomatic relief. However, it is unlikely to regrow substantial amounts of cartilage.
  • Research is ongoing: While a large body of literature exists, especially for knee OA and tendinopathies, research is continually evolving. High-quality, large-scale, double-blind, randomised controlled trials are always beneficial to further solidify evidence.
  • Standardisation challenges: PRP preparation protocols can vary significantly between clinics, including platelet concentration and the presence of white blood cells. These differences can influence study results and make direct comparisons challenging.

To determine if evidence-based insights into PRP for joint pain align with your specific condition and to discuss the most appropriate treatment plan for you, we encourage you to book an appointment with our orthopaedic team.

For further reading, visit the peer-reviewed research on PRP for joint pain.

Expert Tip

“Optimal preparation for your PRP procedure includes staying well-hydrated and discussing any medications with your doctor beforehand, as some may need to be temporarily paused.”

Key Takeaways

  • PRP works by concentrating and delivering the body's own growth factors to stimulate natural tissue healing.
  • Strong evidence supports PRP's efficacy in reducing pain and improving function for mild to moderate knee osteoarthritis.
  • Positive evidence exists for the use of PRP in chronic tendon injuries like tennis elbow and Achilles tendinopathy.
  • Research is ongoing for other joint and soft tissue injuries, with promising early results for ligaments.
  • It's crucial to have realistic expectations and understand that PRP is not a universal cure, and effectiveness can vary.

References

  • Kon E, et al. Platelet-rich plasma for the treatment of articular cartilage pathology: a systematic review. Knee Surg Sports Traumatol Arthrosc. 2012;20(2):299-307.
  • Mishra A, Pavelko T. Treatment of chronic elbow tendinosis with platelet-rich plasma. Am J Sports Med. 2014;42(1):104-111.
  • Roos E, et al. Effectiveness of intra-articular platelet-rich plasma injections in patients with primary knee osteoarthritis: a review. Knee Surg Sports Traumatol Arthrosc. 2017;25(9):2939-2947.

Share this article

Read More